CORE Biomedicine
PrivateLast Round
Series A
Sep 13, 2025
Company Overview
CORE Biomedicine is a biotechnology company that develops therapeutic approaches for the treatment of luminal cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CORE Biomedicine Comps
Public and private peers based on sector, stage, and business model.
CORE Biomedicine Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 13, 2025 | ||||
| Seed | Mar 14, 2025 |
CORE Biomedicine Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| UTokyo Innovation Platform | Series A, Seed |
| Vision Incubate Co., Ltd. | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2025
Raised Series A with UTokyo Innovation Platform and Vision Incubate.
- Mar 14, 2025
Seed round with UTokyo Innovation Platform and Vision Incubate.
CORE Biomedicine Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CORE Biomedicine's valuation, stock price, and market status.
